- Live market news
- Stocks
- CURA
CURA
CURAStock
CURA
Cura is an open source slicing application for 3D printers. It was created by David Braam who was later employed by Ultimaker, a 3D printer manufacturing company, to maintain the software. Cura is available under LGPLv3 license. Cura was initially released under the open source Affero General Public License version 3, but on 28 September 2017 the license was changed to LGPLv3. This change allowed for more integration with third-party CAD applications. Development is hosted on GitHub. Ultimaker Cura is used by over one million users worldwide and handles 1.4 million print jobs per week. It is the preferred 3D printing slicer for Ultimaker 3D printers, but it can be used with other printers as well.
Latest news on CURAranked by Oyticker for market impact
- 62Impact
Curaleaf secures TGA approval for cannabis inhalation device in Australia, expands to New Zealand
Curaleaf International obtained Australian Therapeutic Goods Administration (TGA) registration for a liquid medical cannabis inhalation device—described as an Australian first—and is extending the product to New Zealand, broadening geographic reach in regulated ANZ markets.
CURACannabisHealthcare/PharmaceuticalsMedical Devices - 5Impact
Curaleaf Announces $600K Breast Cancer Charity Donation
Curaleaf reported a $600,000 donation to breast cancer causes as part of a seven-year charitable initiative. This is a corporate social responsibility announcement with no material business, financial or operational impact.
CURLFCURACannabis
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.